Evaluation of prostatic intraepithelial neoplasia after treatment with a 5-alpha-reductase inhibitor (Finasteride) - A methodologic approach

被引:0
|
作者
Montironi, R
Pomante, R
Diamanti, L
Hamilton, PW
Thompson, D
Bartels, PH
机构
[1] ROYAL VICTORIA HOSP,DEPT PATHOL,BELFAST,ANTRIM,NORTH IRELAND
[2] UNIV ARIZONA,CTR OPT SCI,TUCSON,AZ
来源
关键词
prostatic intraepithelial neoplasia; testosterone; 5-alpha-reductase; finasteride; chemoprevention; 5-alpha-reductase inhibitor; diagnostic distance; Bayesian belief network;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
OBJECTIVE: To develop a methodology applicable to the morphologic study of the efficacy of finasteride on prostatic intraepithelial neoplasia (PIN), a putative precursor of prostate cancer. STUDY DESIGN: Three PIN foci were reviewed in two simple prostatectomy specimens from patients with clinical diagnoses of benign prostatic hyperplasia and treated with finasteride for six months. The feasibility of PIN diagnosis and golding based on ''diagnostic distance'' was investigated. It is a measure of the ''extent'' to which the observed features are different from those of the untreated prototypes representing the following diagnostic categories: normal prostate, lo so and high grade PIN and prostatic adenocarcinoma with a cribriform or large acinar pattern. Uncertainty in the PIN diagnosis and grading was dealt with by means of a Bayesian belief network (BBN). RESULTS: The distance measure values gf the three PIN foci from the prototype of untreated, nonneoplastic prostate were 9, 7 and 8, respectively, in relative, arbitrary units. Their distance from the two prostate cancer patterns (large acinar and cribriform) tons as high as 8-10. The distances of these foci from either low or high grade PIN were as low as 5, 3 and 2, and 3, 5 and 4, respectively. BBN produced the highest belief values for PIN, thus confirming the morphology-based and diagnostic distance-supported diagnosis; however, the belief values were low for both grades. CONCLUSION: The results provided by BBN analyses and diagnostic distance measures support the conclusion that this methodology is applicable to assessing the efficacy of finasteride treatment of PIN.
引用
收藏
页码:461 / 470
页数:10
相关论文
共 50 条
  • [1] FINASTERIDE - A 5-ALPHA-REDUCTASE INHIBITOR
    STEINER, JF
    [J]. CLINICAL PHARMACY, 1993, 12 (01): : 15 - 23
  • [2] THE CLINICAL EFFECTS OF A 5-ALPHA-REDUCTASE INHIBITOR, FINASTERIDE, ON BENIGN PROSTATIC HYPERPLASIA
    STONER, E
    [J]. JOURNAL OF UROLOGY, 1992, 147 (05): : 1298 - 1302
  • [3] FINASTERIDE, AN INHIBITOR OF 5-ALPHA-REDUCTASE, SUPPRESSES PROSTATIC DIHYDROTESTOSTERONE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA
    MCCONNELL, JD
    WILSON, JD
    GEORGE, FW
    GELLER, J
    PAPPAS, F
    STONER, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03): : 505 - 508
  • [4] QUALITATIVE AND QUANTITATIVE-EVALUATION OF PROSTATIC HISTOMORPHOLOGY IN RATS FOLLOWING CHRONIC TREATMENT WITH FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR
    PRAHALADA, SR
    KEENAN, KP
    HERTZOG, PR
    GORDON, LR
    PETER, CP
    SOPER, KA
    VANZWIETEN, MJ
    BOKELMAN, DL
    [J]. UROLOGY, 1994, 43 (05) : 680 - 685
  • [5] PHARMACODYNAMIC MODELING OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR
    KO, JC
    JUSKO, WJ
    [J]. PHARMACOTHERAPY, 1995, 15 (04): : 509 - 511
  • [6] THE CLINICAL DEVELOPMENT OF A 5-ALPHA-REDUCTASE INHIBITOR, FINASTERIDE
    STONER, E
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (03): : 375 - 378
  • [7] FINASTERIDE - THE 1ST 5-ALPHA-REDUCTASE INHIBITOR
    SUDDUTH, SL
    KORONKOWSKI, MJ
    SHARIFI, R
    LEE, M
    CALI, TJ
    CHAMBERLAIN, TM
    [J]. PHARMACOTHERAPY, 1993, 13 (04): : 309 - 329
  • [8] FINASTERIDE - A SLOW-BINDING 5-ALPHA-REDUCTASE INHIBITOR
    FALLER, B
    FARLEY, D
    NICK, H
    [J]. BIOCHEMISTRY, 1993, 32 (21) : 5705 - 5710
  • [9] CLINICAL AND HORMONAL EFFECTS OF THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE IN IDIOPATHIC HIRSUTISM
    MOGHETTI, P
    CASTELLO, R
    MAGNANI, CM
    TOSI, F
    NEGRI, C
    ARMANINI, D
    BELLOTTI, G
    MUGGEO, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04): : 1115 - 1121
  • [10] EFFECT OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, ON SERUM GONADOTROPINS IN NORMAL MEN
    RITTMASTER, RS
    LEMAY, A
    ZWICKER, H
    CAPIZZI, TP
    WINCH, S
    MOORE, E
    GORMLEY, GJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02): : 484 - 488